Larsen F - Search Results

1

Joubert AF, Sánchez C, Larsen F. Joubert AF, et al. Among authors: larsen f. Hum Psychopharmacol. 2000 Aug;15(6):439-451. doi: 10.1002/1099-1077(200008)15:6<439::AID-HUP222>3.0.CO;2-H. Hum Psychopharmacol. 2000. PMID: 12404306

2

Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects.

Møller SE, Larsen F, Khant AZ, Rolan PE. Møller SE, et al. Among authors: larsen f. J Clin Psychopharmacol. 2001 Oct;21(5):493-9. doi: 10.1097/00004714-200110000-00007. J Clin Psychopharmacol. 2001. PMID: 11593075 Clinical Trial.

3

Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin.

Priskorn M, Sidhu JS, Larsen F, Davis JD, Khan AZ, Rolan PE. Priskorn M, et al. Among authors: larsen f. Br J Clin Pharmacol. 1997 Aug;44(2):199-202. doi: 10.1046/j.1365-2125.1997.00628.x. Br J Clin Pharmacol. 1997. PMID: 9278211 Free PMC article. Clinical Trial.

4

Lack of citalopram effect on oral digoxin pharmacokinetics.

Larsen F, Priskorn M, Overø KF. Larsen F, et al. J Clin Pharmacol. 2001 Mar;41(3):340-6. doi: 10.1177/00912700122010041. J Clin Pharmacol. 2001. PMID: 11269575 Clinical Trial.

5

Effect of citalopram on plasma levels of oral theophylline.

Møller SE, Larsen F, Pitsiu M, Rolan PE. Møller SE, et al. Among authors: larsen f. Clin Ther. 2000 Dec;22(12):1494-501. doi: 10.1016/s0149-2918(00)83047-7. Clin Ther. 2000. PMID: 11192140 Clinical Trial.

6

Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans.

Sidhu J, Priskorn M, Poulsen M, Segonzac A, Grollier G, Larsen F. Sidhu J, et al. Among authors: larsen f. Chirality. 1997;9(7):686-92. doi: 10.1002/(SICI)1520-636X(1997)9:7<686::AID-CHIR9>3.0.CO;2-5. Chirality. 1997. PMID: 9366029

7

Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.

Joffe P, Larsen FS, Pedersen V, Ring-Larsen H, Aaes-Jørgensen T, Sidhu J. Joffe P, et al. Among authors: larsen fs. Eur J Clin Pharmacol. 1998 May;54(3):237-42. doi: 10.1007/s002280050452. Eur J Clin Pharmacol. 1998. PMID: 9681666 Clinical Trial.

8

Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.

Bundgaard C, Larsen F, Jørgensen M, Gabrielsson J. Bundgaard C, et al. Among authors: larsen f. Eur J Pharm Sci. 2006 Dec;29(5):394-404. doi: 10.1016/j.ejps.2006.08.004. Epub 2006 Aug 12. Eur J Pharm Sci. 2006. PMID: 17014998

9

The pharmacokinetics of escitalopram in patients with hepatic impairment.

Areberg J, Christophersen JS, Poulsen MN, Larsen F, Molz KH. Areberg J, et al. Among authors: larsen f. AAPS J. 2006 Jan 20;8(1):E14-9. doi: 10.1208/aapsj080102. AAPS J. 2006. PMID: 16584121 Free PMC article.

10

Pharmacokinetic/pharmacodynamic feedback modelling of the functional corticosterone response in rats after acute treatment with escitalopram.

Bundgaard C, Larsen F, Jørgensen M, Mørk A. Bundgaard C, et al. Among authors: larsen f. Basic Clin Pharmacol Toxicol. 2007 Mar;100(3):182-9. doi: 10.1111/j.1742-7843.2006.00029.x. Basic Clin Pharmacol Toxicol. 2007. PMID: 17309522 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

794 results

Search Page